173 related articles for article (PubMed ID: 36479979)
21. Moderators and predictors of response to behavior therapy for tics in Tourette syndrome.
Sukhodolsky DG; Woods DW; Piacentini J; Wilhelm S; Peterson AL; Katsovich L; Dziura J; Walkup JT; Scahill L
Neurology; 2017 Mar; 88(11):1029-1036. PubMed ID: 28202705
[TBL] [Abstract][Full Text] [Related]
22. Predictors of the Clinical Course of Tourette Syndrome: A Longitudinal Study.
Groth C; Skov L; Lange T; Debes NM
J Child Neurol; 2019 Dec; 34(14):913-921. PubMed ID: 31411102
[TBL] [Abstract][Full Text] [Related]
23. Familial Risks of Tourette Syndrome and Chronic Tic Disorders. A Population-Based Cohort Study.
Mataix-Cols D; Isomura K; Pérez-Vigil A; Chang Z; Rück C; Larsson KJ; Leckman JF; Serlachius E; Larsson H; Lichtenstein P
JAMA Psychiatry; 2015 Aug; 72(8):787-93. PubMed ID: 26083307
[TBL] [Abstract][Full Text] [Related]
24. [Diagnosis and treatment of tics].
Topka H
MMW Fortschr Med; 2007 May; 149 Suppl 2():4-7; quiz 8. PubMed ID: 17724959
[TBL] [Abstract][Full Text] [Related]
25. Tourette syndrome: the self under siege.
Leckman JF; Bloch MH; Scahill L; King RA
J Child Neurol; 2006 Aug; 21(8):642-9. PubMed ID: 16970864
[TBL] [Abstract][Full Text] [Related]
26. Influence of gender on Tourette syndrome beyond adolescence.
Lichter DG; Finnegan SG
Eur Psychiatry; 2015 Feb; 30(2):334-40. PubMed ID: 25193042
[TBL] [Abstract][Full Text] [Related]
27. Symptoms compatible with long COVID in an Italian pediatric cohort of Tourette patients with and without SARS‑CoV‑2 infection: a short-term follow-up assessment.
Prato A; Salerno AM; Saia F; Maugeri N; Zanini A; Scerbo M; Barone R; Rizzo R
BMC Pediatr; 2023 May; 23(1):222. PubMed ID: 37147589
[TBL] [Abstract][Full Text] [Related]
28. Tourette Syndrome and Chronic Tic Disorders: The Clinical Spectrum Beyond Tics.
Martino D; Ganos C; Pringsheim TM
Int Rev Neurobiol; 2017; 134():1461-1490. PubMed ID: 28805580
[TBL] [Abstract][Full Text] [Related]
29. Tic-related cognition, sensory phenomena, and anxiety in children and adolescents with Tourette syndrome.
Steinberg T; Harush A; Barnea M; Dar R; Piacentini J; Woods D; Shmuel-Baruch S; Apter A
Compr Psychiatry; 2013 Jul; 54(5):462-6. PubMed ID: 23332555
[TBL] [Abstract][Full Text] [Related]
30. [A pediatric cohort with Gilles de la Tourette syndrome].
Urrutia S V; Hernández Ch M
Andes Pediatr; 2021 Dec; 92(6):838-846. PubMed ID: 35506794
[TBL] [Abstract][Full Text] [Related]
31. Rapid onset functional tic-like behaviours in children and adolescents during COVID-19: Clinical features, assessment and biopsychosocial treatment approach.
Han VX; Kozlowska K; Kothur K; Lorentzos M; Wong WK; Mohammad SS; Savage B; Chudleigh C; Dale RC
J Paediatr Child Health; 2022 Jul; 58(7):1181-1187. PubMed ID: 35247213
[TBL] [Abstract][Full Text] [Related]
32. Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome.
Pappert EJ; Goetz CG; Louis ED; Blasucci L; Leurgans S
Neurology; 2003 Oct; 61(7):936-40. PubMed ID: 14557563
[TBL] [Abstract][Full Text] [Related]
33. [Chronic tics and Tourette syndrome in children and adolescents: diagnostic and treatment characteristics].
Zavadenko NN; Doronina OB; Nesterovsky YE
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(1):102-109. PubMed ID: 25909798
[TBL] [Abstract][Full Text] [Related]
34. Dystonic motor and phonic tics in Tourette syndrome.
Baizabal-Carvallo JF; Alonso-Juarez M; Jankovic J
J Neurol; 2022 Oct; 269(10):5312-5318. PubMed ID: 35567613
[TBL] [Abstract][Full Text] [Related]
35. Temporal relationship between premonitory urges and tics in Gilles de la Tourette syndrome.
Brandt VC; Beck C; Sajin V; Baaske MK; Bäumer T; Beste C; Anders S; Münchau A
Cortex; 2016 Apr; 77():24-37. PubMed ID: 26922503
[TBL] [Abstract][Full Text] [Related]
36. Environmental circumstances influencing tic expression in children.
Caurín B; Serrano M; Fernández-Alvarez E; Campistol J; Pérez-Dueñas B
Eur J Paediatr Neurol; 2014 Mar; 18(2):157-62. PubMed ID: 24210363
[TBL] [Abstract][Full Text] [Related]
37. Investigation of gene-environment interactions in relation to tic severity.
Abdulkadir M; Yu D; Osiecki L; King RA; Fernandez TV; Brown LW; Cheon KA; Coffey BJ; Garcia-Delgar B; Gilbert DL; Grice DE; Hagstrøm J; Hedderly T; Heyman I; Hong HJ; Huyser C; Ibanez-Gomez L; Kim YK; Kim YS; Koh YJ; Kook S; Kuperman S; Leventhal B; Madruga-Garrido M; Maras A; Mir P; Morer A; Münchau A; Plessen KJ; Roessner V; Shin EY; Song DH; Song J; Visscher F; Zinner SH; Mathews CA; Scharf JM; Tischfield JA; Heiman GA; Dietrich A; Hoekstra PJ
J Neural Transm (Vienna); 2021 Nov; 128(11):1757-1765. PubMed ID: 34389898
[TBL] [Abstract][Full Text] [Related]
38. Bilineal transmission in Tourette syndrome.
Hanna PA; Janjua FN; Contant CF; Jankovic J
Neurology; 1999 Sep; 53(4):813-8. PubMed ID: 10489047
[TBL] [Abstract][Full Text] [Related]
39. A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette syndrome.
Gilbert DL; Budman CL; Singer HS; Kurlan R; Chipkin RE
Clin Neuropharmacol; 2014; 37(1):26-30. PubMed ID: 24434529
[TBL] [Abstract][Full Text] [Related]
40. Common (Genetic) Links Between Clinics and the Community: New Evidence From a Tourette Syndrome Polygenic Score.
Ronald A
Biol Psychiatry; 2019 Feb; 85(4):281-282. PubMed ID: 30665500
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
